208 related articles for article (PubMed ID: 8486778)
1. P53 mutation in acute T cell lymphoblastic leukemia is of somatic origin and is stable during establishment of T cell acute lymphoblastic leukemia cell lines.
Yeargin J; Cheng J; Yu AL; Gjerset R; Bogart M; Haas M
J Clin Invest; 1993 May; 91(5):2111-7. PubMed ID: 8486778
[TBL] [Abstract][Full Text] [Related]
2. Dissemination and tissue invasiveness in murine acute leukemia associated with acquisition of p53 mutation and loss of wild-type p53.
Hsiao M; Wu CY; Low J; Pattengale P; Yeargin J; Haas M
Mol Carcinog; 1995 Jun; 13(2):112-21. PubMed ID: 7605579
[TBL] [Abstract][Full Text] [Related]
3. Nonhereditary p53 mutations in T-cell acute lymphoblastic leukemia are associated with the relapse phase.
Hsiao MH; Yu AL; Yeargin J; Ku D; Haas M
Blood; 1994 May; 83(10):2922-30. PubMed ID: 8180387
[TBL] [Abstract][Full Text] [Related]
4. Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia.
Kawamura M; Ohnishi H; Guo SX; Sheng XM; Minegishi M; Hanada R; Horibe K; Hongo T; Kaneko Y; Bessho F; Yanagisawa M; Sekiya T; Hayashi Y
Leuk Res; 1999 Feb; 23(2):115-26. PubMed ID: 10071127
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a new human pre-B acute lymphoblastic leukemia cell line (KMO-90) with 1;19 translocation carrying p53 gene alterations.
Sotomatsu M; Hayashi Y; Kawamura M; Yugami S; Shitara T
Leukemia; 1993 Oct; 7(10):1615-20. PubMed ID: 8412323
[TBL] [Abstract][Full Text] [Related]
6. Infrequent mutations in the P53 gene in primary human T-cell acute lymphoblastic leukemia.
Jonveaux P; Berger R
Leukemia; 1991 Oct; 5(10):839-40. PubMed ID: 1961018
[TBL] [Abstract][Full Text] [Related]
7. Establishment, characterization, and chromosomal analysis of new leukemic cell lines derived from MT/p210bcr/abl transgenic mice.
Honda H; Ohno S; Takahashi T; Takatoku M; Yazaki Y; Hirai H
Exp Hematol; 1998 Mar; 26(3):188-97. PubMed ID: 9502614
[TBL] [Abstract][Full Text] [Related]
8. Mutations of the p53 and ras genes in childhood t(1;19)-acute lymphoblastic leukemia.
Kawamura M; Kikuchi A; Kobayashi S; Hanada R; Yamamoto K; Horibe K; Shikano T; Ueda K; Hayashi K; Sekiya T
Blood; 1995 May; 85(9):2546-52. PubMed ID: 7727782
[TBL] [Abstract][Full Text] [Related]
9. Role of the p53 tumor suppressor gene in the pathogenesis and in the suppression of acute lymphoblastic T-cell leukemia.
Yeargin J; Cheng J; Haas M
Leukemia; 1992; 6 Suppl 3():85S-91S. PubMed ID: 1602834
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations.
Cesarman E; Chadburn A; Inghirami G; Gaidano G; Knowles DM
Blood; 1992 Dec; 80(12):3205-16. PubMed ID: 1361372
[TBL] [Abstract][Full Text] [Related]
11. Suppression of acute lymphoblastic leukemia by the human wild-type p53 gene.
Cheng J; Yee JK; Yeargin J; Friedmann T; Haas M
Cancer Res; 1992 Jan; 52(1):222-6. PubMed ID: 1727382
[TBL] [Abstract][Full Text] [Related]
12. Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness.
Hsiao M; Low J; Dorn E; Ku D; Pattengale P; Yeargin J; Haas M
Am J Pathol; 1994 Sep; 145(3):702-14. PubMed ID: 8080050
[TBL] [Abstract][Full Text] [Related]
13. P53 gene mutation in a T-acute lymphoblastic leukemia cell line (loucy) with t(16:20) and 5q- chromosomal aberrations.
Prokocimer M; Peller S; Ben-Bassat H; Goldfinger N; Rotter V
Leuk Lymphoma; 1998 May; 29(5-6):607-11. PubMed ID: 9643574
[TBL] [Abstract][Full Text] [Related]
14. A recurrent stop-codon mutation in succinate dehydrogenase subunit B gene in normal peripheral blood and childhood T-cell acute leukemia.
Baysal BE
PLoS One; 2007 May; 2(5):e436. PubMed ID: 17487275
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the p53 gene in myelodysplastic syndromes.
Jonveaux P; Fenaux P; Quiquandon I; Pignon JM; Laï JL; Loucheux-Lefebvre MH; Goossens M; Bauters F; Berger R
Oncogene; 1991 Dec; 6(12):2243-7. PubMed ID: 1766671
[TBL] [Abstract][Full Text] [Related]
16. Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines.
Cheng J; Haas M
Mol Cell Biol; 1990 Oct; 10(10):5502-9. PubMed ID: 2144611
[TBL] [Abstract][Full Text] [Related]
17. [Alterations of the p53 gene and clinical features in childhood acute lymphoblastic leukemia].
Kawamua M; Hayashi Y; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Horibe K; Hongo T; Ueda K
Rinsho Ketsueki; 1997 Sep; 38(9):719-26. PubMed ID: 9364861
[TBL] [Abstract][Full Text] [Related]
18. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
[TBL] [Abstract][Full Text] [Related]
19. Alternative splicing of the p53 tumor suppressor gene in the Molt-4 T-lymphoblastic leukemia cell line.
Chow VT; Quek HH; Tock EP
Cancer Lett; 1993 Sep; 73(2-3):141-8. PubMed ID: 8221626
[TBL] [Abstract][Full Text] [Related]
20. p53 and N-ras mutations in two new leukemia cell lines established from a patient with multilineage CD7-positive acute leukemia.
Abo J; Inokuchi K; Dan K; Nomura T
Blood; 1993 Nov; 82(9):2829-36. PubMed ID: 7693050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
